Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > Product launch in April

<< Previous

Bullboard Posts

Next >>

Comment by biggdoggon Mar 22, 2022 12:33pm

174 Views

Post# 34534789

RE:RE:RE:RE:RE:Product launch in April

A monopoly is their greatest advantage. There is no customer loyalty to monopolies, the prices are high & allows new company to break into the market. Because they only have one competitor, and they do 1-2 year contracts, Voy should have no issues, especially in the US market. Their model is selling to distribution companies, they don't need a large sales team if selling to distribution companies.

<< Previous

Bullboard Posts

Next >>

The top 10 artificial intelligence penny stocks